Company profile
Mesenbio company profile
Mesenbio is a preclinical biopharmaceutical business based at the University of York. Its Cell Line Extracellular Vesicle Release (CLEVR) technique allows for a more diverse treatment pipeline by overcoming the most common hurdle in extracellular vesicle therapy.
Business identity
- Website
- https://www.mesenbio.net
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Newyork, Argyll and Bute, United Kingdom
- Country code
- GB
- Continent
- Europe